A Study Of Cardiovascular Health In Urologic Cancer Survivorship

Overview

About this study

The purpose of this study is to quantify urologic oncology patient’s understanding of their cardiovascular health (CVH) and to evaluate how a patient’s understanding of their CVH is associated with oncologic outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • >/= 18 years old

  • Documented history of bladder cancer, kidney cancer, or prostate cancer and underwent cystectomy, nephrectomy, or prostatectomy, respectively

 

Exclusion Criteria: 

  • Cystectomy, prostatectomy, or nephrectomy for benign indications

  • Lack of >/= 3 months of follow up

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 09/09/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Gettman, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions